Veith Weilnhammer, MD
veithweilnhammer.bsky.social
Veith Weilnhammer, MD
@veithweilnhammer.bsky.social
I am a neuroscientist, psychiatrist, and psychotherapist. I work on digital technologies to better understand, predict, and improve mental health.

veithweilnhammer.github.io
Pinned
New paper in @brain1878.bsky.social: Healthy people under S-ketamine, an NMDAR antagonist, and people living with schizophrenia, a disorder associated with NMDAR hypofunction, spend more time in an external mode of perception - where noisy sensory signals override knowledge about the world.
@healthtalkscic.bsky.social is an amazing initiative! Many stories follow the same pattern: people are living with mental-health challenges for years before anyone names what’s happening. The delays are heartbreaking and call for scalable tools that can identify & support people much earlier.
November 13, 2025 at 12:13 PM
This is the sobering reality of my morning coffee: 1 billion people are living with a mental-health condition. Countries spend no more than $65 per person on mental health, with 13 mental-health workers for every 100k people.
November 10, 2025 at 8:49 AM
Reposted by Veith Weilnhammer, MD
I am very excited to share our new preprint together with @Isabella Goodwin, @Kelly Diederen, @Emily Hird,
@veithweilnhammer.bsky.social, and @Marta Garrido! Where does predictive processing stand in psychosis research - revisiting Sterzer et al (2018) seven years later. 🧠🔍?
osf.io/preprints/ps...
February 4, 2025 at 8:24 AM
This is a super exciting opening with the best mentor you could ask for!
Exciting postdoc opportunity in our lab! We'll use fMRI and computational modeling to investigate the role of NMDA-receptor function on predictive processing in visual cortex. karriere.upk.ch/Postdoc-100-...
Stellenangebot Postdoc 100% Translational Psychiatry Lab bei Universitäre Psychiatrische Kliniken Basel UPK
Forschung in Klinik für Erwachsene (UPKE)
karriere.upk.ch
February 1, 2025 at 4:06 PM
New paper in @brain1878.bsky.social: Healthy people under S-ketamine, an NMDAR antagonist, and people living with schizophrenia, a disorder associated with NMDAR hypofunction, spend more time in an external mode of perception - where noisy sensory signals override knowledge about the world.
January 19, 2025 at 9:18 PM